PRE-MARKET INDIAN STOCKS NEWS: Reliance Industries (RIL IS) unit Jio Platforms is reportedly planning an IPO of around USD 4bln, or INR 377bln, in the week of October 19th, which could become India’s largest-ever listing

Axis Bank (AXSB IS) - Co. gross advances rose 22.7% Y/Y to INR 13.846trln as of September 30, while total deposits rose 20.7% Y/Y to INR 14.521trln. (Economic Times) Godrej Consumer Products (GCPL IS) - Co. expects Q2 consolidated revenue growth in the high teens, underlying volume growth in the high single digits and consolidated EBITDA growth in the double digits, while standalone revenue growth is seen in the teens. (Moneycontrol) IndusInd Bank (IIB IS) - Co. Q2 net advances rose 11.2% Y/Y to INR 3.62trln, deposits rose 10.1% Y/Y to INR 4.29trln, while CASA ratio fell to 28% from 30.7%. (Moneycontrol) Kotak Mahindra Bank (KMB IS) - Co. Q2 net advances rose 24.7% Y/Y to INR 5.77trln, CASA rose 11.3% Y/Y to INR 2.49trln and total deposits rose 23.2% Y/Y to INR 6.51trln. (Moneycontrol) Marico (MRCO IS) - Co. increased its stake in Satiya Nutraceuticals, owner of The Plant Fix – Plix brand, to 84.09% on a fully diluted basis after acquiring an additional 24.09% stake. (Economic Times) Reliance Industries (RIL IS) - Co. unit Jio Platforms is reportedly planning an IPO of around USD 4bln, or INR 377bln, in the week of October 19th, which could become India’s largest-ever listing. (Economic Times) Trent (TRENT IS) - Co. Q2 standalone revenue from operations, excluding GST, rose 23% Y/Y to INR 57.88bln. (Economic Times) Vedanta (VEDL IS) - Co. board will meet on October 8 to consider and approve its first interim dividend for FY27. (Economic Times) Zydus Lifesciences (ZYDUSLIF IS) - Co. and MSN Laboratories launched generic Riociguat tablets in the US across five strengths, becoming the first companies to launch a generic version of Adempas in the US market. (Economic Times)